Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors

Computer Aided Surgery

Volumn 12, Issue 5, 2007, Pages 253-261

  Brown, William T ^a,b,d   Wu, Xiaodong ^a,b   Wen, B Chen ^a,b   Fowler, John F ^c   Fayad, Fahed ^a   Amendola, Beatriz E ^a   García, Silvio ^a   De La Zerda, Alberto ^a,b   Huang, Zhicong ^a,b   Schwade, James G ^a,b  

^a CyberKnife Center of Miami   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d NONE   (United States)

Author keywords

CyberKnife; Image guided robotic stereotatic radiosurgery (IGR SRS); Lung cancer; Pulmonary metastasis; Stereotactic body radiotherapy (SBRT)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HISTOLOGY; HUMAN; IMAGE GUIDED ROBOTIC STEREOTACTIC RADIOSURGERY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSURGERY; ROBOTICS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; ROBOTICS; SURGERY, COMPUTER-ASSISTED; TIME FACTORS; TREATMENT OUTCOME;

EID: 35648939301     PISSN: 10929088     EISSN: 10970150     Source Type: Journal    
DOI: 10.1080/10929080701684754     Document Type: Article

References (27)

1. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest 2002;121:1155-1158.
2. Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003;41:1-11.
3. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-154.
4. Narayan S, Henning GT, Ten Haken RK, Sullivan MA, Martel MK, Hayman JA. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004;44:79-88.
5. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-870.
6. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M. Extracranial stereotactic radio-ablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955.
7. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-196.
8. McGarry RC, Papiez L, Williams M, Whiteford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-1015.
9. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 2006;51:97-103.
10. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, Yamashita T, Niibe Y et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-1631.
11. Radiation Therapy Oncology Group. RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer. 2004.
12. Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thoracic Oncol 2006;1:802-809.
13. Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp MM Jr, Rodebaugh R, Weinhous MS, Le QT. Stereotactic radiosurgery for lung tumors:preliminary report of phase I trail. Ann Thoracic Surg 2003;75(4):1097-1101.
14. Brown WT, Perman M, Wu X et al. Image guided robotic stereotactic radiosurgery for lung tumors. In: Mould RF, editor. Robotic Radiosurgery. Vol. I. Sunnyvale, CA: The CyberKnife Society Press; 2005. pp 255-269.
15. Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003;55(3):724-735.
16. Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, Kelly JF. Starkschall G. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 2003;56:106-113.
17. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, Carette MF, Rosenwald JC et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000;48:1015-1024.
18. Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996;34(2):297-302.
19. Fowler JF, Tome WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004;60(4):1241-1256.
20. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-4839.
21. Slotman BJ, Antonisse IE, Njo KH. Limited field irradiation in early stage (T1-2 N0) non small cell lung cancer. Radiotherap Oncol 1996;41:41-44.
22. Mehta MP, Wang W, Johnson D, Wagner H, Schiller J, Veeder M, Belani C. Induction chemotherapy followed by standard radiotherapy vs. hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non small cell lung cancer: Phase III study of Eastern Cooperative Oncology Group (ECOG 2597). Int J Radiat Oncol Biol Phys 2003;57(2 Suppl):S141.
23. Cheung PCF, Yeung LTF, Basrur V, Ung YC, Balogh J, Danjoux CE. Accelerated hypofractionation for early stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2002;54(4):1014-1023.
24. Maguire PD, Marks LB, Sibley GS, Herndon II JE, Clough RW, Light KL, Hernando ML, Antoine PA, Anscher MS. Gy and beyond: Hyperfractionated accelerated radiotherapy for non small lung cancer. J Clin Oncol 2001;19(3):705-711.
25. Yan D. Adapt radiotherapy to temporal biology targets assessed using biological images. In: Proceedings of the 14th International Conference on the Use of Computers in Radiotherapy (ICCR), Seoul, Korea, 2004.
26. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004;59:242-249.
27. Fowler JF. Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment - continually rapid proliferation unmasked. Radiother Oncol 1991;22(3):156-158.